OPTA

(redirected from osteopetrosis)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to osteopetrosis: osteogenesis imperfecta
AcronymDefinition
OPTAOnafhankelijke Post en Telecommunicatie Autoriteit
OPTAOsteopetrosis
OPTAOptimum Performance Theoretically Attainable
OPTAOperational Programme Technical Assistance (EU)
OPTAOrthotic & Prosthetic Technological Association
OPTAOpen Packet Telephony Architecture (Cisco)
References in periodicals archive ?
Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome.
Osteopetrosis is a rare hereditary condition characterized by an increase in bone density.
Wallace Beltsville [Maryland] Agricultural Research Center collaborated with veterinary researchers at the University of Nebraska and University of Wyoming to identify the gene mutation responsible for the disorder and to develop a diagnostic test that identifies osteopetrosis carriers.
Doctors realized that rather than fluid on the brain, Andrew had a rare condition called malignant infantile osteopetrosis.
Thicker frontal bones, such as those seen in osteopetrosis, tend to form smaller, less aerated sinuses.
Karen has osteopetrosis which causes visual-impairment and mobility problems.
IFN-gamma is currently marketed for the treatment of chronic granulomatous disease and malignant osteopetrosis, and is in clinical trials for the treatment of idiopathic pulmonary fibrosis, certain forms of cancer and tuberculosis.
An imbalance between bone formation and resorption causes metabolic diseases such as osteoporosis and osteopetrosis (a family of diseases characterized by increased bone mass due to decreased bone resorption).
Interferon beta-1a (Avonex) and interferon beta-1b (Betaseron) are approved for multiple sclerosis; interferon gamma-1b (Actimmune) reduces the frequency and severity of infections associated with chronic granulomatous disease and delays progression of malignant osteopetrosis.
even minuscule amounts of fluoride will cause osteosclerosis, spondylosis, osteopetrosis, and goiter, and we cannot afford to run the risk of producing such serious systemic disturbances in applying what is a doubtful procedure to prevent dental disfigurements among children.
Actimmune is currently marketed in the United States by InterMune for the treatment of two rare congenital diseases, chronic granulomatous disease and severe, malignant osteopetrosis.